X-154412130-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000116.5(TAFAZZIN):c.154G>T(p.Glu52*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000116.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000116.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAFAZZIN | MANE Select | c.154G>T | p.Glu52* | stop_gained | Exon 2 of 11 | NP_000107.1 | Q16635-1 | ||
| TAFAZZIN | c.208G>T | p.Glu70* | stop_gained | Exon 2 of 11 | NP_001427785.1 | ||||
| TAFAZZIN | c.208G>T | p.Glu70* | stop_gained | Exon 2 of 10 | NP_001290394.1 | A6XNE1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAFAZZIN | TSL:1 MANE Select | c.154G>T | p.Glu52* | stop_gained | Exon 2 of 11 | ENSP00000469981.1 | Q16635-1 | ||
| TAFAZZIN | TSL:1 | c.208G>T | p.Glu70* | stop_gained | Exon 2 of 10 | ENSP00000419854.3 | A0A499FJ53 | ||
| TAFAZZIN | TSL:1 | c.154G>T | p.Glu52* | stop_gained | Exon 2 of 10 | ENSP00000481037.1 | Q16635-3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 24
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at